Compare OCGN & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCGN | SNDL |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Pharmaceuticals and Biotechnology |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 387.3M | 432.6M |
| IPO Year | N/A | 2019 |
| Metric | OCGN | SNDL |
|---|---|---|
| Price | $1.56 | $1.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $7.00 | $5.00 |
| AVG Volume (30 Days) | 4.1M | ★ 4.8M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,370,000.00 | ★ $683,170,243.00 |
| Revenue This Year | $35.93 | $5.48 |
| Revenue Next Year | N/A | $3.10 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 14.26 | 4.43 |
| 52 Week Low | $0.52 | $1.15 |
| 52 Week High | $1.90 | $2.89 |
| Indicator | OCGN | SNDL |
|---|---|---|
| Relative Strength Index (RSI) | 60.13 | 41.22 |
| Support Level | $1.32 | $1.63 |
| Resistance Level | $1.65 | $2.34 |
| Average True Range (ATR) | 0.11 | 0.10 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 68.18 | 4.11 |
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.